|  Help  |  About  |  Contact Us

Publication : Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis.

First Author  Waidmann O Year  2020
Journal  Sci Rep Volume  10
Issue  1 Pages  16264
PubMed ID  33004985 Mgi Jnum  J:297450
Mgi Id  MGI:6472401 Doi  10.1038/s41598-020-73387-4
Citation  Waidmann O, et al. (2020) Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis. Sci Rep 10(1):16264
abstractText  The nuclear factor kappa beta (NFkappaB) signaling pathway plays an important role in liver homeostasis and cancer development. Tax1-binding protein 1 (Tax1BP1) is a regulator of the NFkappaB signaling pathway, but its role in the liver and hepatocellular carcinoma (HCC) is presently unknown. Here we investigated the role of Tax1BP1 in liver cells and murine models of HCC and liver fibrosis. We applied the diethylnitrosamine (DEN) model of experimental hepatocarcinogenesis in Tax1BP1(+/+) and Tax1BP1(-/-) mice. The amount and subsets of non-parenchymal liver cells in in Tax1BP1(+/+) and Tax1BP1(-/-) mice were determined and activation of NFkappaB and stress induced signaling pathways were assessed. Differential expression of mRNA and miRNA was determined. Tax1BP1(-/-) mice showed increased numbers of inflammatory cells in the liver. Furthermore, a sustained activation of the NFkappaB signaling pathway was found in hepatocytes as well as increased transcription of proinflammatory cytokines in isolated Kupffer cells from Tax1BP1(-/-) mice. Several differentially expressed mRNAs and miRNAs in livers of Tax1BP1(-/-) mice were found, which are regulators of inflammation or are involved in cancer development or progression. Furthermore, Tax1BP1(-/-) mice developed more HCCs than their Tax1BP1(+/+) littermates. We conclude that Tax1BP1 protects from liver cancer development by limiting proinflammatory signaling.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

0 Expression